SET Nuclear Oncogene (SET) (N-Term) Peptide
SET
Hôte: Synthetic
BP, IHC, WB, IP
N° du produit ABIN8111551
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 6 à 9 jours ouvrables
Aperçu rapide pour SET Nuclear Oncogene (SET) (N-Term) Peptide (ABIN8111551)
Antigène
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP)
-
-
Protein Region
- N-Term
-
Fonction
- SET Peptide - N-terminal region
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-SET antibody ( ARP56542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Sujet
-
Background Information: SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-indu
Alternative Symbols: 2PP2A, I2PP2A, IGAAD, PHAPII, TAF-IBETA, TAF-I, IPP2A2
-
Poids moléculaire
- 32kDa
-
ID gène
- 6418
-
NCBI Accession
- NP_003002
-
UniProt
- B2RCX0
Antigène
-
Vous êtes ici:
